Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote USD

Shanghai Kai Kai Industry Company Limited (900943.SS)

Compare
0.4970
-0.0110
(-2.17%)
As of 10:16:17 AM GMT+8. Market Open.
Loading Chart for 900943.SS
  • Previous Close 0.5080
  • Open 0.5020
  • Bid 0.4980 x --
  • Ask 0.5030 x --
  • Day's Range 0.4900 - 0.5070
  • 52 Week Range 0.3210 - 0.6200
  • Volume 61,066
  • Avg. Volume 320,916
  • Market Cap (intraday) 339.266M
  • Beta (5Y Monthly) -0.02
  • PE Ratio (TTM) 16.57
  • EPS (TTM) 0.0300
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (1.35%)
  • Ex-Dividend Date Jul 15, 2024
  • 1y Target Est --

Shanghai Kai Kai Industry Company Limited engages in the production, distribution, and sale of pharmaceutical and clothing products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei and Yunshang life brand, as well as produces Chinese patent medicine preparations under the Jing and Que brands. It is also involved in the wholesale and retail of sweaters, cardigans, and clothing series under the Kai Kai brand, as well as school uniforms under the Mangnessen brand. The company was founded in 1997 and is headquartered in Shanghai, China.

www.chinesekk.com

492

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 900943.SS

View More

Performance Overview: 900943.SS

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

900943.SS
8.97%
SSE Composite Index (000001.SS)
2.51%

1-Year Return

900943.SS
16.24%
SSE Composite Index (000001.SS)
6.29%

3-Year Return

900943.SS
10.78%
SSE Composite Index (000001.SS)
2.26%

5-Year Return

900943.SS
4.93%
SSE Composite Index (000001.SS)
15.12%

Compare To: 900943.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 900943.SS

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    346.77M

  • Enterprise Value

    316.86M

  • Trailing P/E

    16.98

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.87

  • Price/Book (mrq)

    1.47

  • Enterprise Value/Revenue

    2.22

  • Enterprise Value/EBITDA

    25.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.13%

  • Return on Assets (ttm)

    1.02%

  • Return on Equity (ttm)

    10.90%

  • Revenue (ttm)

    1.05B

  • Net Income Avi to Common (ttm)

    54.12M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.62M

  • Total Debt/Equity (mrq)

    3.82%

  • Levered Free Cash Flow (ttm)

    -14.16M

Research Analysis: 900943.SS

View More

Company Insights: 900943.SS

Research Reports: 900943.SS

View More

People Also Watch